We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
FDA trade union: trade union: annual returns, rules, statement to members, decisions and other related documents.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
How to get fast-track approval of medical devices during COVID-19.
How to conform with the legal requirements for placing medical devices on the market.
Find out which COVID-19 test products have been approved.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
How test manufacturers or distributors can apply for approval of their tests to sell on the UK market.
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
This document contains Other related Documents for FDA
Rules for FDA.
Guidance for UK wholesalers and manufacturers on how to import human medicines including unlicensed medicines, how to apply for a licence and how much it costs.
Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without delay
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
Annual returns for FDA, as submitted to the Certification Office.
Members Statement for FDA
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).